| 000 | 01348 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250513202505.0 | ||
| 264 | 0 | _c20000215 | |
| 008 | 200002s 0 0 eng d | ||
| 022 | _a0284-186X | ||
| 024 | 7 |
_a10.1080/028418699432310 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSerin, M | |
| 245 | 0 | 0 |
_aRadiation therapy and concurrent cisplatin in management of locoregionally advanced nasopharyngeal carcinomas. _h[electronic resource] |
| 260 |
_bActa oncologica (Stockholm, Sweden) _c1999 |
||
| 300 |
_a1031-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aCarcinoma _xdrug therapy |
| 650 | 0 | 4 |
_aCisplatin _xtherapeutic use |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNasopharyngeal Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRadiation Injuries |
| 650 | 0 | 4 | _aRadiotherapy Dosage |
| 650 | 0 | 4 | _aSurvival Rate |
| 700 | 1 | _aErkal, H S | |
| 700 | 1 | _aCakmak, A | |
| 773 | 0 |
_tActa oncologica (Stockholm, Sweden) _gvol. 38 _gno. 8 _gp. 1031-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/028418699432310 _zAvailable from publisher's website |
| 999 |
_c10620212 _d10620212 |
||